The disintegrin-like metalloproteinase ADAM 10 is involved in coinstitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion

被引:533
作者
Hundhausen, C
Misztela, D
Berkhout, TA
Broadway, N
Saftig, P
Reiss, K
Hartmann, D
Fahrenholz, F
Postina, R
Matthews, V
Kallen, KJ
Rose-John, S
Ludwig, A
机构
[1] Univ Kiel, Inst Biochem, D-24118 Kiel, Germany
[2] GlaxoSmithKline, Dept Atherosclerosis, Stevenage, Herts, England
[3] GlaxoSmithKline, Dept Gene Express & Prot Biochem, Stevenage, Herts, England
[4] Catholic Univ Louvain, Ctr Human Genet, B-3000 Louvain, Belgium
[5] Johannes Gutenberg Univ Mainz, Inst Biochem, D-6500 Mainz, Germany
关键词
D O I
10.1182/blood-2002-12-3775
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The CX3C chemokine fractalkine (CX3CL1) exists as a membrane-expressed protein promoting cell-cell adhesion and as a soluble molecule inducing chemotaxis. Transmembrane CX3CL1 is converted into its soluble form by defined proteolytic cleavage (shedding), which can be enhanced by stimulation withphorbol-12-myristate-13-acetate (PMA). PMA-induced CX3CL1 shedding has been shown to involve the tumor necrosis factor-alpha-converting enzyme (TACE), whereas the constitutive cleavage in unstimulated cells remains elusive. Here we demonstrate a role of the closely related disintegrin-like metalloproteinase 10 (ADAM10) in the constitutive CX3CL1 cleavage. The hydroxamate GW280264X, capable of blocking TACE as Well as ADAM10, proved to be an effective inhibitor of the constitutive and the PMA-inducible CX3CL1 cleavage in CX3CL-expressing ECV-304 cells (CX3CL1-ECV-304), whereas GI254023X, preferentially blocking ADAM10 but not TACE, reduced the constitutive, cleavage only. Overexpression of ADAM10 in COS-7 cells enhanced constitutive cleavage of CX3CL1 and, more importantly, in murine fibroblasts deficient of ADAM10 constitutive CX3CL1 cleavage was markedly reduced. Thus, ADAM10 contributes to the constitutive shedding of CX3CL1 in un-stimulated cells. Addressing the functional role of CX3CL1 shedding for the adhesion of monocytic cells via membrane-expressed CX3CL1, we found that THP-1 cells adhere to CX3CL1-ECV-304 cells but detach in the course of vigorous washing. Inhibition of ADAM10-mediated CX3CL1 shedding not only increased adhesive properties of CX3CL1-ECV-304 cells but also prevented de-adhesion of bound THP-1 cells. Our data demonstrate that ADAM10 is involved in the constitutive cleavage of CX3CL1 and thereby may regulate the recruitment of monocytic cells to CX3CL1-expressing cell layers. (C) 2003 by The American Society of Hematology.
引用
收藏
页码:1186 / 1195
页数:10
相关论文
共 69 条
[51]   Fractalkine is an epithelial and endothelial cell-derived chemoattractant for intraepithelial lymphocytes in the small intestinal mucosa [J].
Muehlhoefer, A ;
Saubermann, LJ ;
Gu, XB ;
Luedtke-Heckenkamp, K ;
Xavier, R ;
Blumberg, RS ;
Podolsky, DK ;
MacDermott, RP ;
Reinecker, HC .
JOURNAL OF IMMUNOLOGY, 2000, 164 (06) :3368-3376
[52]  
Müllberg J, 2000, EUR CYTOKINE NETW, V11, P27
[53]   N-hydroxyformamide peptidomimetics as TACE/matrix metalloprotease inhibitors:: Oral activity via P1′ isobutyl substitution [J].
Musso, DL ;
Andersen, MW ;
Andrews, RC ;
Austin, R ;
Beaudet, EJ ;
Becherer, JD ;
Bubacz, DG ;
Bickett, DM ;
Chan, JH ;
Conway, JG ;
Cowan, DJ ;
Gaul, MD ;
Glennon, KC ;
Hedeen, KM ;
Lambert, MH ;
Leesnitzer, MA ;
McDougald, DL ;
Mitchell, JL ;
Moss, ML ;
Rabinowitz, MH ;
Rizzolio, MC ;
Schaller, LT ;
Stanford, JB ;
Tippin, TK ;
Warner, JR ;
Whitesell, LG ;
Wiethe, RW .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (16) :2147-2151
[54]   Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation [J].
Pan, Y ;
Lloyd, C ;
Zhou, H ;
Dolich, S ;
Deeds, J ;
Gonzalo, JA ;
Vath, J ;
Gosselin, M ;
Ma, JY ;
Dussault, B ;
Woolf, E ;
Alperin, G ;
Culpepper, J ;
GutierrezRamos, JC ;
Gearing, D .
NATURE, 1997, 387 (6633) :611-617
[55]  
Papadopoulos EJ, 1999, EUR J IMMUNOL, V29, P2551, DOI 10.1002/(SICI)1521-4141(199908)29:08<2551::AID-IMMU2551>3.0.CO
[56]  
2-T
[57]   Design of selective and soluble inhibitors of tumor necrosis factor-α converting enzyme (TACE) [J].
Rabinowitz, MH ;
Andrews, RC ;
Becherer, JD ;
Bickett, DM ;
Bubacz, DG ;
Conway, JG ;
Cowan, DJ ;
Gaul, M ;
Glennon, K ;
Lambert, MH ;
Leesnitzer, MA ;
McDougald, DL ;
Moss, ML ;
Musso, DL ;
Rizzolio, MC .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (24) :4252-4267
[58]   Cellular localization of fractalkine at sites of inflammation: antigen-presenting cells in psoriasis express high levels of fractalkine [J].
Raychaudhuri, SP ;
Jiang, WY ;
Farber, EM .
BRITISH JOURNAL OF DERMATOLOGY, 2001, 144 (06) :1105-1113
[59]   A role for fractalkine and its receptor (CX3CR1) in cardiac allograft rejection [J].
Robinson, LA ;
Nataraj, C ;
Thomas, DW ;
Howell, DN ;
Griffiths, R ;
Bautch, V ;
Patel, DD ;
Feng, LL ;
Coffman, TM .
JOURNAL OF IMMUNOLOGY, 2000, 165 (11) :6067-6072
[60]  
Ruth JH, 2001, ARTHRITIS RHEUM, V44, P1568, DOI 10.1002/1529-0131(200107)44:7<1568::AID-ART280>3.0.CO